Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

IXICO reassures with trading update says Shore Capital

Company has a healthy order book and strong cash position

IXICO PLC’s (LON:IXI) April trading update was reassuring said broker Shore Capital, with a healthy order book and strong cash position.

“While 2021 and 2022 are likely to be more modest in terms of growth (and margin progression) for the business vs prior years, the market opportunity is compelling and IXICO’s underlying data analytics platform as truly differentiated.

“The focus on commercialisation and profitability by CEO Giulio Cerroni continues to deliver meaningful growth for the business and investors, and we would anticipate further positive momentum going forward.”

Shares rose 8% to 89.5p.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK